Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • 200 Young South Africans
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Shabir Madhi

Covid-19 in South Africa: Which approach should we take now?
Coronavirus
/ 3 February 2022

Covid-19 in South Africa: Which approach should we take now?

The trick to tackling Covid-19 at this stage is to be adaptive. The government’s one-size-fits-all approach is broken; we need to be more flexible. But we should not throw away hard-won lessons

By Philip Machanick
Omicron variant of Covid the dominant strain in South Africa
Opinion
/ 1 December 2021

Omicron variant of Covid the dominant strain in South Africa

It’s time to get vaccinated because the Covid viral firestorm is spreading fast

By Howard Armistead
South Africa opens up vaccinations for 12 to 17 year-olds
Coronavirus
/ 15 October 2021

South Africa opens up vaccinations for 12 to 17 year-olds

Vaccinology researcher Professor Shabir Madhi said young people were being vaccinated to reduce the number of people who could transmit the virus and the focus should instead be on people over the age of 50

By Eunice Masson
What we know about the C.1.2 Covid variant, so far
Coronavirus
/ 2 September 2021

What we know about the C.1.2 Covid variant, so far

Experts studying the new variant, C.1.2, are surprised by its substantial mutations but are confident current vaccines will be effective against it

By Marcia Zali and M&G Data Desk
As the Covid-19 third-wave hits, how many South Africans have had the virus already?
Health
/ 29 May 2021

As the Covid-19 third-wave hits, how many South Africans have had the virus already?

Increasing seroprevalence in South Africa could help curb the disastrous effects a third wave could have on communities. But no one is out of the woods yet

By Chris Bateman
Slow registration delays South Africa’s vital vaccine roll-out
Coronavirus
/ 27 May 2021

Slow registration delays South Africa’s vital vaccine roll-out

This has resulted in demand exceeding supply — or vice versa — at many vaccination sites

By Chris Bateman
South Africa not yet in a third wave, says health department
Health
/ 13 May 2021

South Africa not yet in a third wave, says health department

The number of Covid-19 cases in the country has increased by an average of 46% over seven days

By Eunice Masson
Johnson & Johnson vaccines could arrive in South Africa next week
Coronavirus
/ 10 February 2021

Johnson & Johnson vaccines could arrive in South Africa next week

We spoke to experts, looked at the data and relistened to the health department’s briefings to break down the revised roll-out plan

By Bhekisisa Team
Jury still out on pregnant women getting a Covid jab
Coronavirus
/ 9 February 2021

Jury still out on pregnant women getting a Covid jab

Few trials have been carried out on women expecting babies

By Chris Bateman
Second doses of AstraZeneca vaccine are still on their way to South Africa
Coronavirus
/ 8 February 2021

Second doses of AstraZeneca vaccine are still on their way to South Africa

The department of health and experts briefed the media on Sunday, after a study showed the vaccine is not highly effective against the new variant

By Eunice Masson
South Africa pauses Covid-19 vaccine rollout after disappointing AstraZeneca results
Coronavirus
/ 8 February 2021

South Africa pauses Covid-19 vaccine rollout after disappointing AstraZeneca results

SA’s one-million doses of the AstraZeneca vaccine will expire by early April — unless India’s Serum Institute can safely extend their use-by date.

By Laura López González
The vaccines arrive on Monday: Who will protect them and who will get them first?
Coronavirus
/ 29 January 2021

The vaccines arrive on Monday: Who will protect them and who will get them first?

The first batch of vaccines is almost here, but a top government adviser says achieving herd immunity by the end of the year is ‘unrealistic’

By Chris Bateman
Vaccine trial results due in December
Coronavirus
/ 7 August 2020

Vaccine trial results due in December

If successful, it will then have to be manufactured and distributed

By Athandiwe Saba
People’s behaviour stoking Gauteng pandemic
Coronavirus
/ 9 July 2020

People’s behaviour stoking Gauteng pandemic

The active case count of Gauteng surpasses that of whole countries. Workers at clinics report a ‘concerning’ relaxation of basic health protocols

By M&G Data Desk and Thando Maeko
Eusebius McKaiser: How do we decide whose lives matter most?
Coronavirus
/ 12 May 2020

Eusebius McKaiser: How do we decide whose lives matter most?

The way Covid-19 death facts are reported (age and comorbidities) reflects how old people and those with chronic conditions are valued. Scientifically there’s an argument for this, but morally it’s troubling

By Eusebius McKaiser
Question marks surround Madagascar’s Covid-19 ‘miracle cure’
Africa
/ 11 May 2020

Question marks surround Madagascar’s Covid-19 ‘miracle cure’

Despite Malagasy President Andry Rajoelina’s claims of a cure for Covid-19, experts say ‘there is absolutely no evidence’ that is true

By Aanu Adeoye and Simon Allison
No image available
Article
/ 10 May 2013

Jabs deplete vaccine budget but dramatically cut child mortality

Prevenar and Rotarix have emptied paediatric wards but the coverage is still too low.

By Amy Green
No image available
Article
/ 2 September 2011

Ahead of the game

The National Research Foundation (NRF) Awards are handed out each year to recognise researchers whose research has put them at the top of their field.

By Advertorial Supplement

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }